<DOC>
	<DOCNO>NCT01331902</DOCNO>
	<brief_summary>The purpose study evaluate efficacy nicorandil achievement maximal coronary hyperemia compare adenosine .</brief_summary>
	<brief_title>Comparison Hyperemic Efficacy Between Nicorandil Adenosine Fractional Flow Reserve ( FFR ) Measurement</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Adenosine</mesh_term>
	<mesh_term>Nicorandil</mesh_term>
	<criteria>non infarct relate , patient moderate coronary artery stenosis normal leave ventricular ejection fraction echocardiogram infarctrelated artery clinically unstable state collateral blood flow target vessel show atrioventricular block electrocardiogram reduce leave ventricular ejection fraction ( &lt; 50 % ) leave ventricular hypertrophy echocardiogram contraindication adenosine bronchial asthma</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Adenosine</keyword>
	<keyword>Nicorandil</keyword>
	<keyword>Fractional Flow Reserve</keyword>
	<keyword>Maximal Hyperemia</keyword>
</DOC>